A
Acessa Health
Minimally invasive, uterus sparing procedure for women with symptomatic fibroids
About Acessa Health
Acessa Health is revolutionizing the standard of care for uterine fibroids through its innovative Acessa procedure. This minimally invasive treatment is designed to provide significant symptom relief for women suffering from uterine fibroids, which are benign growths in the uterus that can cause severe discomfort. The company serves women who are seeking alternatives to traditional surgical options, offering a scientifically backed procedure that has been recommended by 98% of women in clinical studies. Operating in the healthcare market, Acessa Health's business model focuses on providing advanced medical solutions through partnerships with physicians and healthcare providers. Revenue is generated through the sale of the Acessa procedure and related medical devices to healthcare facilities. The company is committed to improving women's health and quality of life by offering effective, less invasive treatment options.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Aug 2020 | $80M | $80M | Hologic | — |
| SERIES A✓Equity / VC | Jun 2017 | $30M | $120M | Undisclosed | — |
Growth signals
Latest recorded traffic for Acessa Health is 1.1K monthly website visits, down 88.4% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Acessa Health in the Austin ecosystem
The Acessa Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
Hologic
S3 Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Acessa Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Acessa Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







